Limitations of Standard Immunosuppressive Treatment in ANCA-Associated Vasculitis and Lupus Nephritis

Publisher： Karger

E-ISSN： 1660-2110|128|3-4|205-215

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.128, Iss.3-4, 2015-0, pp. : 205-215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Addition of Infliximab to Standard Therapy for ANCA-Associated Vasculitis

By  

Nephron Clin Pract, Vol. 117, Iss. 2, 2010-08 ,pp. : c89-c97

Karger

Access to resources Recommend Favorite

Successful conception and pregnancy in p‐ANCA‐associated vasculitis in course of treatment with immunosuppressive drugs and renal replacement therapy

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 4, 2015-05 ,pp. : 470-472

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rituximab in ANCA-Associated Vasculitis: Fad or Fact?

By  

Nephron Clin Pract, Vol. 118, Iss. 2, 2010-12 ,pp. : c182-c188

Karger

Access to resources Recommend Favorite

Phosphorylcholine antibodies are diminished in ANCA‐associated vasculitis

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 45, Iss. 7, 2015-07 ,pp. : 686-691

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prolonged Treatment with Low-Dose Intravenous Pulse Cyclophosphamide May Reduce Rate of Relapse in ANCA-Associated Vasculitis

By  

Nephron Clin Pract, Vol. 97, Iss. 4, 2004-11 ,pp. : c154-c159

Karger

Access to resources Recommend Favorite